Ancient and modern: hints of a core post‐transcriptional network driving chemotherapy resistance in ovarian cancer-Reference-Cited by-同舟云学术

Ancient and modern: hints of a core post‐transcriptional network driving chemotherapy resistance in ovarian cancer

Published:2017-08 Issue:1 Volume:9 Page:
ISSN:1757-7004
Container-title:WIREs RNA
language:en
Short-container-title:WIREs RNA

Author:

Blagden Sarah¹,Abdel Mouti Mai¹,Chettle James¹

Affiliation:

1. Department of Oncology University of Oxford Oxford UK

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wrna.1432

Reference135 articles.

1. Cancer Research Statistics. Available at:http://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/ovarian‐cancer. (Accessed March 25 2017).

2. Ovarian cancer

3. Integrated genomic analyses of ovarian carcinoma;Cancer Genome Atlas Research Network;Nature,2011

4. PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions

5. Mutant p53 reactivation by small molecules makes its way to the clinic

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive compounds from Morchella esculenta as potential inhibitors of RNA-binding protein La in ovarian cancer: a molecular modeling and quantum mechanics approach;In Silico Pharmacology;2024-04-20

2. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer;Frontiers in Genetics;2022-11-08

3. KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer;Life Sciences;2022-03

4. RNA-binding proteins in ovarian cancer: a novel avenue of their roles in diagnosis and treatment;Journal of Translational Medicine;2022-01-21

5. RNA-binding proteins modulate drug sensitivity of cancer cells;Emerging Topics in Life Sciences;2021-07-30